BR112015001562A2 - biotinas e composições - Google Patents

biotinas e composições

Info

Publication number
BR112015001562A2
BR112015001562A2 BR112015001562A BR112015001562A BR112015001562A2 BR 112015001562 A2 BR112015001562 A2 BR 112015001562A2 BR 112015001562 A BR112015001562 A BR 112015001562A BR 112015001562 A BR112015001562 A BR 112015001562A BR 112015001562 A2 BR112015001562 A2 BR 112015001562A2
Authority
BR
Brazil
Prior art keywords
biotins
compositions
Prior art date
Application number
BR112015001562A
Other languages
English (en)
Portuguese (pt)
Inventor
Sedel Frédéric
Original Assignee
Hopitaux Paris Assist Publique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hopitaux Paris Assist Publique filed Critical Hopitaux Paris Assist Publique
Publication of BR112015001562A2 publication Critical patent/BR112015001562A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR112015001562A 2012-07-26 2013-04-29 biotinas e composições BR112015001562A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1257254A FR2993780B1 (fr) 2012-07-26 2012-07-26 Methode de traitement de la sclerose en plaque
US13/644,615 US8835487B2 (en) 2012-07-26 2012-10-04 Method of treating multiple sclerosis
PCT/EP2013/058936 WO2014016003A1 (en) 2012-07-26 2013-04-29 Use of biotin for the treatment of multiple sclerosis

Publications (1)

Publication Number Publication Date
BR112015001562A2 true BR112015001562A2 (pt) 2017-07-04

Family

ID=47294963

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015001562A BR112015001562A2 (pt) 2012-07-26 2013-04-29 biotinas e composições

Country Status (25)

Country Link
US (5) US8835487B2 (https=)
EP (2) EP2729143B1 (https=)
JP (1) JP6208235B2 (https=)
KR (1) KR101967502B1 (https=)
CN (2) CN109908140A (https=)
AU (1) AU2013295370B2 (https=)
BR (1) BR112015001562A2 (https=)
CA (1) CA2879434C (https=)
CY (1) CY1116304T1 (https=)
DK (2) DK2729143T3 (https=)
EA (1) EA030478B1 (https=)
ES (3) ES2811074T3 (https=)
FR (1) FR2993780B1 (https=)
HK (1) HK1207583A1 (https=)
HR (1) HRP20150260T1 (https=)
HU (1) HUE024558T2 (https=)
IL (1) IL236790A (https=)
LT (1) LT2857019T (https=)
ME (1) ME02060B (https=)
PL (1) PL2729143T3 (https=)
PT (2) PT2857019T (https=)
RS (1) RS53893B1 (https=)
SI (2) SI2857019T1 (https=)
SM (1) SMT201500057B (https=)
WO (1) WO2014016003A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2958166B1 (fr) * 2010-04-06 2012-07-13 Assist Publ Hopitaux De Paris Compositions pharmaceutiques fortement dosees en biotine
FR2993780B1 (fr) 2012-07-26 2015-02-13 Assist Publ Hopitaux De Paris Methode de traitement de la sclerose en plaque
US9789092B2 (en) 2013-04-29 2017-10-17 Assistance Publique—Hopitaux de Paris Biotin for use in treating X-linked adrenoleukodystrophy
WO2016129362A1 (ja) * 2015-02-13 2016-08-18 ユニマテック株式会社 含フッ素共重合体およびこれを有効成分とする表面改質剤
EP3072513A1 (en) 2015-03-26 2016-09-28 Medday Biotin for treating Amyotrophic lateral sclerosis
US20170135969A1 (en) 2015-11-12 2017-05-18 Jds Therapeutics, Llc Topical arginine-silicate-inositol for wound healing
RU2638803C2 (ru) * 2016-06-09 2017-12-15 Общество С Ограниченной Ответственностью "Валента-Интеллект" Таблетки биотина с замедленным высвобождением и способ их получения
RU2611415C1 (ru) * 2015-11-17 2017-02-21 Общество С Ограниченной Ответственностью "Валента - Интеллект" ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ ТЕРАПЕВТИЧЕСКИМ ЭФФЕКТОМ В ОТНОШЕНИИ ДЕМИЕЛИНИЗИРУЮЩИХ ЗАБОЛЕВАНИЙ (Варианты)
WO2017086835A1 (ru) * 2015-11-17 2017-05-26 Общество С Ограниченной Ответственностью "Валента-Интеллект" Фармацевтическая композиция, обладающая терапевтическим эффектом в отношении демиелинизирующих заболеваний (варианты)
EP3275439A1 (en) 2016-07-29 2018-01-31 Medday Pharmaceuticals Method for treating hepatic encephalopathy
GB2568849B (en) * 2016-09-01 2022-08-10 Nutrition 21 Llc Magnesium biotinate compositions and methods of use
RU2639488C1 (ru) * 2017-04-06 2017-12-21 Общество С Ограниченной Ответственностью "Валента - Интеллект" Фармацевтическая композиция, содержащая биотин, и способ ее получения
US20200155510A1 (en) * 2018-11-13 2020-05-21 Jds Therapeutics, Llc Treatment of autoimmune disorders, such as relapsing remitting multiple sclerosis and clinically isolated syndrome with biotin compositions
CN112076310A (zh) * 2019-06-14 2020-12-15 苏州融析生物科技有限公司 一种治疗多发性硬化的药物组合物及其制备
GB2613672A (en) 2019-12-16 2023-06-14 Nutrition 21 Llc Methods of production of aginine-silicate complexes
CA3157712C (en) 2020-01-01 2024-01-23 Jotiram PALKAR Synergistic nutritional compositions for enhancing atp efficiency

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3609165A (en) 1968-07-19 1971-09-28 Research Corp 1,3-diazabicyclo {8 3.1.0{9 {0 hex-3-enes
JPH0995448A (ja) 1995-09-29 1997-04-08 Calpis Food Ind Co Ltd:The 血中ビオチン濃度の増加方法およびビオチン含有飲食品
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
US5789401A (en) 1997-08-08 1998-08-04 Nutrition 21 High-dose chromium/biotin treatment of type II diabetes
US6664039B1 (en) 1998-10-14 2003-12-16 California Institute Of Technology Methods and compositions for modulating neurodegeneration
UA73492C2 (en) * 1999-01-19 2005-08-15 Aromatic heterocyclic compounds as antiinflammatory agents
DE19903241A1 (de) 1999-01-28 2000-08-03 Merck Patent Gmbh Galenische Formulierung
EP1536698A1 (en) 2002-08-23 2005-06-08 DSM IP Assets B.V. Novel nutraceutical compositions comprising biotin
DE60333207D1 (de) 2002-09-30 2010-08-12 Daiichi Sankyo Co Ltd Pantethin enthaltendes teilchenförmiges produkt
DE10341240A1 (de) * 2003-09-08 2005-04-07 Aventis Pharma Deutschland Gmbh Substituierte Thienoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
AU2003300167B2 (en) * 2003-12-31 2010-09-16 K-Pax Vitamins, Inc. Nutrient compositions and methods for enhanced effectiveness of the immune system
IL162288A0 (en) * 2004-06-01 2005-11-20 Future Products Man S A Compositions and methods for treating neurodegenerative disorders
BG66011B1 (bg) * 2005-05-25 2010-10-29 Райна Щонова Състав от растителен произход
BR112012015084A2 (pt) 2009-12-23 2017-03-07 Lupin Ltd composição farmacêutica de liberação lenta de iloperidone
FR2958166B1 (fr) * 2010-04-06 2012-07-13 Assist Publ Hopitaux De Paris Compositions pharmaceutiques fortement dosees en biotine
FR2993780B1 (fr) 2012-07-26 2015-02-13 Assist Publ Hopitaux De Paris Methode de traitement de la sclerose en plaque

Also Published As

Publication number Publication date
CA2879434A1 (en) 2014-01-30
WO2014016003A1 (en) 2014-01-30
US10201528B2 (en) 2019-02-12
US8835487B2 (en) 2014-09-16
AU2013295370B2 (en) 2017-03-02
SI2729143T1 (sl) 2015-05-29
US20140030331A1 (en) 2014-01-30
US20160324830A1 (en) 2016-11-10
US20190117626A1 (en) 2019-04-25
PT2729143E (pt) 2015-03-16
JP2015522630A (ja) 2015-08-06
US20140348920A1 (en) 2014-11-27
SMT201500057B (it) 2015-05-05
EP2729143B1 (en) 2014-12-31
FR2993780A1 (fr) 2014-01-31
US20190117625A1 (en) 2019-04-25
EP2729143A1 (en) 2014-05-14
KR101967502B1 (ko) 2019-04-09
US9351961B2 (en) 2016-05-31
ES2532364T3 (es) 2015-03-26
KR20150042799A (ko) 2015-04-21
RS53893B1 (sr) 2015-08-31
CY1116304T1 (el) 2017-02-08
DK2729143T3 (en) 2015-03-23
CN109908140A (zh) 2019-06-21
EP2857019A1 (en) 2015-04-08
IL236790A (en) 2017-09-28
AU2013295370A1 (en) 2015-02-19
CN104602689A (zh) 2015-05-06
HRP20150260T1 (hr) 2015-05-08
FR2993780B1 (fr) 2015-02-13
JP6208235B2 (ja) 2017-10-04
ES2811074T3 (es) 2021-03-10
LT2857019T (lt) 2020-09-10
DK2857019T3 (da) 2020-08-17
CA2879434C (en) 2019-04-23
SI2857019T1 (sl) 2020-10-30
EA201590270A1 (ru) 2015-11-30
ES2626079T3 (es) 2017-07-21
HUE024558T2 (hu) 2016-02-29
ME02060B (me) 2015-05-20
PT2857019T (pt) 2020-07-24
HK1207583A1 (en) 2016-02-05
EA030478B1 (ru) 2018-08-31
EP2857019B1 (en) 2020-05-27
PL2729143T3 (pl) 2015-05-29

Similar Documents

Publication Publication Date Title
LT3725778T (lt) Enzalutamido kompozicijos
BR112015003227A2 (pt) processos de clicoconjugação e composições
EP2763896A4 (en) UNMANUFACTURED AIRCRAFT WITH SEVERAL ROTORS
DK2859055T3 (da) Polymercoatings
BR112015001562A2 (pt) biotinas e composições
EP2880683A4 (en) BVA INTERPOSER
DK2825087T3 (da) Otoscanner
EP2809145A4 (en) CHLOROPLAST TRANSIT PEPTIDES
DK2839013T3 (da) Ikke-disruptiv-gen-targetering
EP2814472A4 (en) DITHIOAMINE REDUCING AGENTS
DK2873977T3 (da) Dobbeltdækker-rørdispenser
BR112014032798A2 (pt) composição
BR112015002651A2 (pt) composições cosméticas
DE112012006109A5 (de) Okklusionsschienenanordnung
CO6990736A2 (es) Pirrolidina-2-carboxamidas sustituídas
DK2854722T3 (da) Stomipose
EP2941099A4 (en) SWITCHING DEVICE
ME03413B (me) Kompozicije које sadrže peg i askorbat
EP2831482A4 (en) Flange gasket
EP2816694A4 (en) FLAT CABLE WINDING DEVICE
EP2903015A4 (en) BREAKERS
DK2825157T3 (da) Aminosyrelipider
EP2809729A4 (en) Siloxane polyether copolymers
EP2862179A4 (en) FUEL CURRENT INSPECTION PROBE
EP2869113A4 (en) DISPLAY DEVICE FOR VEHICLE

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL